CINECA IRIS Institutional Research Information System

SIMIELE, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.036
EU - Europa 1.477
AS - Asia 884
AF - Africa 66
SA - Sud America 45
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 4
Totale 4.549
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.973
DE - Germania 563
IT - Italia 390
CN - Cina 364
IN - India 164
GB - Regno Unito 80
JP - Giappone 66
FR - Francia 60
VN - Vietnam 46
ID - Indonesia 44
NL - Olanda 41
RU - Federazione Russa 41
CA - Canada 37
AU - Australia 35
CZ - Repubblica Ceca 35
ES - Italia 29
KR - Corea 29
IR - Iran 28
UA - Ucraina 28
PL - Polonia 25
SE - Svezia 24
AT - Austria 23
EG - Egitto 23
MX - Messico 23
TR - Turchia 20
TH - Thailandia 19
BE - Belgio 18
HK - Hong Kong 18
ZA - Sudafrica 18
IE - Irlanda 17
HU - Ungheria 15
TW - Taiwan 15
PK - Pakistan 14
BR - Brasile 13
CO - Colombia 12
RO - Romania 12
CH - Svizzera 11
HR - Croazia 9
PH - Filippine 9
SG - Singapore 9
FI - Finlandia 8
MY - Malesia 8
NG - Nigeria 8
RS - Serbia 8
CL - Cile 7
DK - Danimarca 7
IL - Israele 7
LT - Lituania 7
SA - Arabia Saudita 7
AR - Argentina 6
GR - Grecia 6
DZ - Algeria 4
PE - Perù 4
AE - Emirati Arabi Uniti 3
EU - Europa 3
KE - Kenya 3
PT - Portogallo 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
ZW - Zimbabwe 3
BY - Bielorussia 2
CI - Costa d'Avorio 2
GE - Georgia 2
JO - Giordania 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BG - Bulgaria 1
CR - Costa Rica 1
CY - Cipro 1
GT - Guatemala 1
IQ - Iraq 1
JE - Jersey 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MG - Madagascar 1
MR - Mauritania 1
MT - Malta 1
MU - Mauritius 1
MW - Malawi 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PR - Porto Rico 1
UG - Uganda 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 4.549
Salva come PNG Salva come JPEG
Città #
Fairfield 210
Houston 186
Woodbridge 146
Ashburn 129
Torino 129
Seattle 127
Buffalo 104
Ann Arbor 90
Santa Cruz 90
Cambridge 82
Wilmington 74
Beijing 70
Leawood 55
Nürnberg 48
Chicago 37
San Diego 34
Jinan 33
University Park 30
Dong Ket 26
Nanjing 22
Shanghai 21
Jakarta 20
Los Angeles 19
Wuhan 19
Hangzhou 17
Dallas 16
Guangzhou 16
Hebei 16
Rome 16
Shenyang 16
Hyderabad 15
Changsha 14
Szeged 14
Warsaw 14
Dublin 13
Las Vegas 13
Mountain View 13
Boardman 12
Gurgaon 12
Ottawa 12
Pisa 12
Tokyo 12
Cairo 11
Milan 11
Paris 11
Taipei 11
Bangkok 10
Bengaluru 10
Brooklyn 10
Central 10
Phoenix 10
Tettnang 10
Amsterdam 9
Council Bluffs 9
Haikou 9
Istanbul 9
New Delhi 9
Cagliari 8
Chengdu 8
Fleming Island 8
Hanoi 8
Herndon 8
Landshut 8
Stockholm 8
Tianjin 8
Bangalore 7
Chandler 7
Clearwater 7
Cuneo 7
Henderson 7
Lanzhou 7
Mumbai 7
Clifton 6
Düsseldorf 6
Hamburg 6
Jiaxing 6
Lake Forest 6
London 6
Louvain 6
Lucknow 6
Madrid 6
Muizenberg 6
Ningbo 6
Osaka 6
Riyadh 6
Taiyuan 6
Buenos Aires 5
Ceska 5
Durban 5
Durham 5
Fuzhou 5
Helsinki 5
Kiel 5
Modena 5
New York 5
Omaha 5
Riva 5
San Francisco 5
Taizhou 5
Tehran 5
Totale 2.470
Salva come PNG Salva come JPEG
Nome #
Cannabis FM2: optimization and standardization of galenic preparations., file e27ce42e-b157-2581-e053-d805fe0acbaa 916
Ultra Performance Liquid Chromatography PDA Method for Determination of Tigecycline in Human Plasma., file e27ce426-fc6b-2581-e053-d805fe0acbaa 487
HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC)., file e27ce426-eda7-2581-e053-d805fe0acbaa 481
UPLC-MS/MS method for quantification of the azathioprine metabolites 6-mercaptoguanosine and 6-methylmercaptopurine riboside in peripheral blood mononuclear cells., file e27ce427-c7f3-2581-e053-d805fe0acbaa 367
Inosine triphosphatase polymorphisms and ribavirin pharmacokinetics as determinants of ribavirin-associate anemia in patients receiving standard anti-HCV treatment., file e27ce426-edaf-2581-e053-d805fe0acbaa 291
Sviluppo di protocolli operativi standard per l’ottimizzazione di preparazioni galeniche allestite con cannabis “FM2”, file e27ce42e-b155-2581-e053-d805fe0acbaa 279
Intracellular accumulation of ritonavir combined with different protease inhibitors and correlations between concentrations in plasma and peripheral blood mononuclear cells., file e27ce42a-2054-2581-e053-d805fe0acbaa 187
High interpatient variability of raltegravir CSF concentrations in HIV-positive patients: a pharmacogenetic analysis., file e27ce426-fdb2-2581-e053-d805fe0acbaa 183
Pharmacokinetics of 400 mg of raltegravir once daily in combination with atazanavir/ritonavir plus two nucleoside/nucleotide reverse transcriptase inhibitors., file e27ce42a-3e63-2581-e053-d805fe0acbaa 171
Evaluation of the mean corpuscular volume of peripheral blood mononuclear cells of HIV patients by a coulter counter to determine intracellular drug concentrations., file e27ce426-dd32-2581-e053-d805fe0acbaa 161
Development of Standard Operating Protocols for the Optimization of Cannabis-Based Formulations for Medical Purposes, file e27ce42e-7b55-2581-e053-d805fe0acbaa 129
Elvitegravir/Cobicistat/Tenofovir/Emtricitabine Penetration in the Cerebrospinal Fluid of Three HIV-Positive Patients, file e27ce429-b6a7-2581-e053-d805fe0acbaa 123
Seminal pharmacokinetics and antiviral efficacy of once-daily maraviroc plus lopinavir/ritonavir in HIV-infected patients., file e27ce426-f675-2581-e053-d805fe0acbaa 122
Impact of Different Procedures of Galenic Formulations of Cannabis on Cannabinoids Contents, file e27ce42e-813d-2581-e053-d805fe0acbaa 118
Correlation between Thiopurine S-Methyltransferase Genotype and Adverse Events in Inflammatory Bowel Disease Patients, file e27ce42e-885a-2581-e053-d805fe0acbaa 97
Tenofovir and emtricitabine cerebrospinal fluid-to-plasma ratios correlate to the extent of blood-brainbarrier damage., file e27ce426-d682-2581-e053-d805fe0acbaa 95
Cannabis-Based Oral Formulations for Medical Purposes: Preparation, Quality and Stability, file e27ce431-6848-2581-e053-d805fe0acbaa 71
Raltegravir penetration in seminal plasma of healthy volunteers., file e27ce426-cc1e-2581-e053-d805fe0acbaa 62
Tenofovir clearance is reduced in hiv-positive patients with subclinical tubular impairment, file e27ce429-b2bb-2581-e053-d805fe0acbaa 62
Class-specific relative genetic contribution for key antiretroviral drugs, file e27ce42a-686a-2581-e053-d805fe0acbaa 50
Cerebrospinal Fluid Inhibitory Quotients of Antiretroviral Drugs in HIV-positive Patients are Associated with Compartmental Viral Control., file e27ce42a-5667-2581-e053-d805fe0acbaa 45
Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms., file e27ce42a-40fa-2581-e053-d805fe0acbaa 33
A description of Cannabinoid levels in Cannabis oil by high-performance liquid chromatography-mass spectrometry in a reference laboratory of North-Italy, file e27ce435-5bc4-2581-e053-d805fe0acbaa 33
A UHPLC-MS/MS method for the quantification of direct antiviral agents simeprevir, daclatasvir, ledipasvir, sofosbuvir/GS-331007, dasabuvir, ombitasvir and paritaprevir, together with ritonavir, in human plasma, file e27ce433-9ce4-2581-e053-d805fe0acbaa 31
MONITORING OF VIROLOGICAL AND PHARMACOLOGICAL CEREBROSPINAL FLUID PARAMETERS IN HAART-TREATED HIV-POSITIVE PATIENTS IN THE CLINICAL SETTING, file e27ce426-d012-2581-e053-d805fe0acbaa 23
Negative Predictive Value of IL28B, SLC28A2, and CYP27B1 SNPs and Low RBV Plasma Exposure for Therapeutic Response to PEG/IFN-RBV Treatment., file e27ce426-eb1c-2581-e053-d805fe0acbaa 16
Tenofovir clearance is reduced in hiv-positive patients with subclinical tubular impairment, file e27ce429-b616-2581-e053-d805fe0acbaa 9
Analytical validation of a novel UHPLC-MS/MS method for 19 antibiotics quantification in plasma: Implementation in a LC-MS/MS Kit, file 759e7a82-b9cd-484a-8443-c3076f5394e4 8
Cerebrospinal Fluid Inhibitory Quotients of Antiretroviral Drugs in HIV-positive Patients are Associated with Compartmental Viral Control., file e27ce428-c2c0-2581-e053-d805fe0acbaa 6
Plasma and Intracellular Imatinib Concentrations in Patients With Chronic Myeloid Leukemia, file e27ce428-c622-2581-e053-d805fe0acbaa 6
UPLC-MS/MS method for the simultaneous quantification of anti-HBV nucleos(t)ides analogs: Entecavir, lamivudine, telbivudine and tenofovir in plasma of HBV infected patients, file e27ce42c-9b03-2581-e053-d805fe0acbaa 5
UPLC-MS/MS method for quantification of the azathioprine metabolites 6-mercaptoguanosine and 6-methylmercaptopurine riboside in peripheral blood mononuclear cells., file e27ce428-ca8b-2581-e053-d805fe0acbaa 4
UPLC–MS/MS method for the simultaneous quantification of three new antiretroviral drugs, dolutegravir, elvitegravir and rilpivirine, and other thirteen antiretroviral agents plus cobicistat and ritonavir boosters in human plasma, file e27ce42b-ee07-2581-e053-d805fe0acbaa 4
A UPLC-MS/MS method for the simultaneous plasma quantification of all isomeric forms of the new anti-HCV protease inhibitors boceprevir and telaprevir., file e27ce432-2134-2581-e053-d805fe0acbaa 4
Development and validation of a useful UPLC-MS/MS method for quantification of total and phosphorylated-ribavirin in peripheral blood mononuclear cells of HCV+ patients, file e27ce426-fbb6-2581-e053-d805fe0acbaa 3
Development and validation of a useful HPLC-UV method for quantification of total and phosphorylated-ribavirin in blood and erythrocytes of HCV+ patients, file e27ce426-edae-2581-e053-d805fe0acbaa 2
Clinical pharmacology of tenofovir clearance: a pharmacokinetic/pharmacogenetic study on plasma and urines, file e27ce428-b8e7-2581-e053-d805fe0acbaa 2
Efavirenz pharmacogenetics in a cohort of Italian patients, file e27ce428-bc10-2581-e053-d805fe0acbaa 2
Intracellular antiviral activity of low-dose ritonavir in boosted protease inhibitors regimens., file e27ce428-c7de-2581-e053-d805fe0acbaa 2
QUALITATIVE AND QUANTITATIVE EVALUATION OF DIFFERENT PHARMACEUTICAL PRODUCTS CONTAINING QUETIAPINE: BRAND VERSUS GENERIC, file e27ce42a-ae8b-2581-e053-d805fe0acbaa 2
A UHPLC-MS/MS method for the quantification of direct antiviral agents simeprevir, daclatasvir, ledipasvir, sofosbuvir/GS-331007, dasabuvir, ombitasvir and paritaprevir, together with ritonavir, in human plasma, file e27ce42a-c0ee-2581-e053-d805fe0acbaa 2
HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC)., file e27ce42a-ee0b-2581-e053-d805fe0acbaa 2
Cannabinoids concentration variability in cannabis olive oil galenic preparations, file e27ce42c-9627-2581-e053-d805fe0acbaa 2
Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients, file e27ce42c-987e-2581-e053-d805fe0acbaa 2
Negative Predictive Value of IL28B, SLC28A2, and CYP27B1 SNPs and Low RBV Plasma Exposure for Therapeutic Response to PEG/IFN-RBV Treatment., file e27ce432-0d6d-2581-e053-d805fe0acbaa 2
A validated HPLC-MS method for quantification of the CCR5 inhibitor maraviroc in HIV+ human plasma, file e27ce426-fea8-2581-e053-d805fe0acbaa 1
Rilpivirine Pharmacokinetics in 3 HIV-Positive Patients With Liver Cirrhosis Concomitantly Receiving Pantoprazole, file e27ce428-b63c-2581-e053-d805fe0acbaa 1
Development and validation of an ultra performance liquid chromatography tandem mass method for sildenafil and N-desmethyl sildenafil plasma determination and quantification, file e27ce428-b63f-2581-e053-d805fe0acbaa 1
Dried Plasma/Blood Spots for Monitoring Antiretroviral Treatment Efficacy and Pharmacokinetics: a Cross-sectional Study in Rural Burundi., file e27ce428-b6aa-2581-e053-d805fe0acbaa 1
Class-specific relative genetic contribution for key antiretroviral drugs, file e27ce428-baf0-2581-e053-d805fe0acbaa 1
Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms., file e27ce428-c0b7-2581-e053-d805fe0acbaa 1
Development and validation of an UPLC-PDA method to quantify daptomycin in human plasma and in dried plasma spots., file e27ce428-c2dc-2581-e053-d805fe0acbaa 1
High interpatient variability of raltegravir CSF concentrations in HIV-positive patients: a pharmacogenetic analysis., file e27ce428-c358-2581-e053-d805fe0acbaa 1
Elvitegravir/Cobicistat/Tenofovir/Emtricitabine Penetration in the Cerebrospinal Fluid of Three HIV-Positive Patients, file e27ce429-b6a6-2581-e053-d805fe0acbaa 1
Development and validation of a useful HPLC-UV method for quantification of total and phosphorylated-ribavirin in blood and erythrocytes of HCV+ patients, file e27ce42b-f4a4-2581-e053-d805fe0acbaa 1
Development and validation of a new UPLC-PDA method to quantify linezolid in plasma and in dried plasma spots, file e27ce42b-f4a8-2581-e053-d805fe0acbaa 1
A LC-MS method to quantify tenofovir urinary concentrations in treated patients, file e27ce431-c024-2581-e053-d805fe0acbaa 1
Intrapatient and interpatient pharmacokinetic variability of raltegravir in the clinical setting., file e27ce431-cdd1-2581-e053-d805fe0acbaa 1
Development and validation of a simultaneous extraction procedure for HPLC-MS quantification of daptomycin, amikacin, gentamicin, and rifampicin in human plasma., file e27ce431-e3a9-2581-e053-d805fe0acbaa 1
HPLC-MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions., file e27ce431-e3ab-2581-e053-d805fe0acbaa 1
An HPLC-PDA Method for the Simultaneous Quantification of the HIV Integrase Inhibitor Raltegravir, the New Nonnucleoside Reverse Transcriptase Inhibitor Etravirine, and 11 Other Antiretroviral Agents in the Plasma of HIV-Infected Patients, file e27ce431-e478-2581-e053-d805fe0acbaa 1
A validated high-performance liquid chromatography-ultraviolet method for quantification of the CCR5 inhibitor maraviroc in plasma of HIV-infected patients., file e27ce431-e479-2581-e053-d805fe0acbaa 1
Influence of CYP2B6 and ABCB1 SNPs on nevirapine plasma concentrations in Burundese HIV-positive patients using dried sample spot devices., file e27ce431-eb75-2581-e053-d805fe0acbaa 1
Sequential therapy with entecavir and PEG-INF in patients affected by chronic hepatitis B and high levels of HBV-DNA with non-D genotypes., file e27ce432-0dc8-2581-e053-d805fe0acbaa 1
Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521 T>C polymorphism., file e27ce432-1daf-2581-e053-d805fe0acbaa 1
Totale 4.722
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.964
article - articoli 0
book - libri 0
conference - conferenze 1.748
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.712
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019403 0 0 0 26 15 15 18 37 28 59 111 94
2019/2020964 61 42 32 109 90 50 79 76 90 211 60 64
2020/2021900 72 65 48 73 67 86 81 79 62 101 88 78
2021/2022915 96 68 65 111 86 34 77 56 54 39 141 88
2022/2023837 65 60 136 93 81 52 59 69 93 74 39 16
2023/202478 21 28 28 1 0 0 0 0 0 0 0 0
Totale 4.722